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Abstract
Introduction
Publishing protocols of randomized controlled trials (RCT) facilitates a more detailed descrip-
tion of study rational, design, and related ethical and safety issues, which should promote
transparency. Little is known about how the practice of publishing protocols developed over
time. Therefore, this study describes the worldwide trends in volume and methodological
quality of published RCT protocols.
Methods
A systematic search was performed in PubMed and EMBASE, identifying RCT protocols
published over a decade from 1 September 2001. Data were extracted on quality character-
istics of RCT protocols. The primary outcome, methodological quality, was assessed by indi-
vidual methodological characteristics (adequate generation of allocation, concealment of
allocation and intention-to-treat analysis). A comparison was made by publication period
(First, September 2001- December 2004; Second, January 2005-May 2008; Third, June
2008-September 2011), geographical region and medical specialty.
Results
The number of published RCT protocols increased from 69 in the first, to 390 in the third
period (p<0.0001). Internal medicine and paediatrics were the most common specialty top-
ics. Whereas most published RCT protocols in the first period originated from North America
(n = 30, 44%), in the second and third period this was Europe (respectively, n = 65, 47% and
n = 190, 48%, p = 0.02). Quality of RCT protocols was higher in Europe and Australasia,
compared to North America (OR = 0.63, CI = 0.40–0.99, p = 0.04). Adequate generation of
allocation improved with time (44%, 58%, 67%, p = 0.001), as did concealment of allocation
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(38%, 53%, 55%, p = 0.03). Surgical protocols had the highest quality among the three spe-
cialty topics used in this study (OR = 1.94, CI = 1.09–3.45, p = 0.02).
Conclusion
Publishing RCT protocols has become popular, with a five-fold increase in the past decade.
The quality of published RCT protocols also improved, although variation between geo-
graphical regions and across medical specialties was seen. This emphasizes the impor-
tance of international standards of comprehensive training in RCT methodology.
Introduction
In 2004, the International Committee of Medical Journals Editors (ICMJE) announced that
randomized controlled trials (RCT) should be registered in a public trials registry before the
recruitment of the first participant. This registration is now a condition for publication of the
final trial results.[1–3]
Although trial registries have many benefits, some authors have suggested that they do not
provide full and transparent information about RCT methodology.[4–6] Furthermore, a sys-
tematic review highlighted changes between the information in trial registries and the full
RCT publication.[7] Publishing RCT protocols gives authors the opportunity to fully explain
the rationale and proposed methods for their trial as well as related ethical and safety issues.[7,
8] Although publishing RCT protocols is not a common practice yet, it would potentially bene-
fit trial users and complement the information in trial registries.[9, 10] Moreover, some
experts have suggested that it should be mandatory to publish a protocol in order to minimise
publication bias, false sample size reporting, switching of endpoints and increase transparency.
In recent years, several studies have addressed trends in the number and methodological
quality of RCTs, [7, 11–13] and some addressed the discrepancies between RCTs and their ini-
tially published protocols.[14–16] However, no previous study has analysed trends in the pub-
lication of study protocols. Thus, little is known about trends in the practice of publishing trial
protocols and their methodological quality. Since clinical medicine depends heavily on RCTs,
transparency and high quality of RCT protocols is crucial. Therefore, the aim of this study was
to assess worldwide trends in the volume and methodological quality of published protocols of
RCTs through the first decade of the 21st century.
Methods
Aims
This study aimed to analyse trends in the publication of RCT protocols by assessing their vol-
ume and methodological quality across specialties and geographic regions.
Search strategy and selection process
PubMed and EMBASE were searched for trial protocols published in a ten-year period (1 Sep-
tember 2001 to 1 September 2011). In order to interpret the current status of methodological
protocol quality, the time interval of ten years was chosen to minimize sampling error, and to
ensure sustainability of the results. Also it provides an interesting insight in the development
of methodological quality over time. The search syntax was as follows: (design rationale trial
AND (randomised OR randomized)) OR (protocol trial AND (randomised or randomized)).
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All retrieved abstracts were screened according to the inclusion and exclusion criteria by two
reviewers (KC, IA). If the relevance was uncertain, the full text of the article was obtained and
reviewed. All disagreements were resolved through discussion and reaching consensus by
including a third reviewer (MGB).[17] Protocols were included if they described a RCTs,
defined as any prospective study assessing the effect of health care interventions in humans,
randomly allocated to one of at least two study groups. Studies were excluded when (1) trial
results were listed rather than protocols, (2) the study was not a RCT, (3) the study was not a
study in humans, (4) the publication was not written in the English language, (5) no abstract
was present, (6) no full text was present, and (7) the protocol was published after the study had
been completed.
Study outcomes
The primary study outcome was methodological quality, with as secondary outcome the vol-
ume of published protocols. Methodological quality was assessed on two parameters:
1. Individual methodological characteristics: All protocols were appraised according to a list
adapted from the Cochrane risk of bias assessment tool and Chan and Altman’s review
including the following characteristics [11, 18]:
• Specification of primary outcome: adequate if primary outcome was explicitly specified in
the protocol.
• Sample size calculation: adequate if performed and reported.
• Generation of allocation sequence: adequate if method of generation was reported and
considered adequate (i.e. computer, random table, shuffle of cards).
• Concealment of treatment allocation: adequate if method of concealment was reported
and considered adequate (i.e. envelopes, central unit for randomization, pharmacy, and
independent statistician).
• Any blinding: adequate if any type of blinding was performed.
• Double blinding: adequate if both patient and one of the following were blinded: physician,
observer, adjudication / consensus committee.
• Type of analysis: adequate if intention-to-treat analysis was explicitly mentioned.
2. High vs. low quality designs: a trial was designated as ‘high quality’ if all three of the follow-
ing methodological items were adequately reported: generation of allocation, concealment
of allocation and intention-to-treat analysis. Blinding was not included as an item. Some
have claimed that the role of blinding is overstated [19, 20]. Blinding may be impossible in
some surgical trials.[21–24] Estimating correct implementation (or legitimate non-imple-
mentation) of blinding will not be possible, considering the great variety of possibilities to
implement blinding among medical specialties. Therefore concealment of sequence genera-
tion was chosen instead, since it is a more generalizable parameter.[25]
Data extraction and definitions
The following geographical, publishing and epidemiological characteristics were extracted:
geographical region, specialty (based on the corresponding author and divided into the follow-
ing (arbitrary) categories: Internal medicine and paediatrics, primary care, surgery (including
subspecialties) and other), number of study centres, study arms (two arms, or three and more),
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number of randomized patients, trial design, funding (any kind of involvement of the industry
was stated as commercial), presence of written informed consent, presence of a data safety
monitoring board and plan for dealing with adverse events.
Data analysis
Characteristics and outcomes of included protocols were compared for three approximately
equal periods: September 2001 to December 2004, January 2005 to May 2008 and June 2008 to
September 2011.
Because of the search strategy used, only study protocols published in the last 4 months of
the year 2001 and the first 8 months of the year 2011 were included. A random sample of pub-
lications from those years was added to the database as substitute for the missing months in
2001 and 2011. This was conducted according to the following manner: the number of publi-
cations per month of included protocols that were scored on quality in 2001 and 2011 respec-
tively was calculated. This mean was multiplied by the number of missing months (8 in 2001
and 4 months in 2011 respectively). This resulted in 3 protocols being added to 2001 and 40 to
2011. The added protocols were randomly selected from period 1 and period 3, respectively.
Subgroup analyses were based on geographical region and medical specialty. The rational
for examining geographical variation as well as medical specialties was that previous research
demonstrated differences in methodological quality of surgical trials between continents.[26]
Dichotomous outcomes were presented as the number (percentage) of events, whereas medi-
ans and interquartile ranges were used for continuous data. Study groups were compared by
Fisher exact, χ2 and Mann-Whitney U tests, as appropriate. A p-value of<0.05 was considered
significant. The odds ratio (OR) with the corresponding 95% confidence intervals (95% CIs)
was calculated for comparison of methodological quality between subgroups by means of uni-
variate and multivariate logistic regression. All variables were included in the univariate analy-
sis. Variables showing potential association (p<0.2) in the univariate analysis were
subsequently included in the multivariate analysis.[27] IBM SPSS Statistics for Windows Ver-
sion 20.0 (IBM Corp., Armonk, NY, USA) was used for all statistical analysis.
Results
Selection process
Our search identified a total of 11 782 records. The selection process is depicted in figure A
of the supporting information. The screening of the titles resulted in the selection of 6074
potentially relevant publications, and after screening by title and abstract, 615 publications
remained. After final selection of full-text, 553 eligible protocols were identified. A random
sample of 43 protocols was added to the database, resulting in a total of 596 protocols.
General characteristics and volume
Table 1 shows the clinical and epidemiological characteristics of the included protocols.
The number of published protocols increased substantially over time, with 69, 137 and 390
published in the three periods, respectively (p<0.0001) (figure A in the supporting informa-
tion, and figure B of the supporting information). This constitutes a five-fold increase between
the first and third period. In the first period, most published RCT protocols originated from
North America, n = 30 (44%), while Europe was the most common in the second and third
periods, n = 65 (47%) and n = 190 (48%), respectively.
‘Internal medicine and paediatrics’ was the most common specialty topic for RCTs of the
four categories used, in all periods. Overall an increase in the absolute number of protocols
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was observed, although the numbers remained relatively low in the surgical category (n = 6,
19, 41). The proportion of non-industry-funded trials almost doubled between the first and
last time period from 27 (39%) to 254 (65%), (p<0.0001). There was a decrease in the reporting
of the use of a data safety committee: from 54% in the first period to about 36% in the third
period, (p = 0.02).
Methodological quality
Methodological quality of the included protocols is presented in Table 2.
Table 1. Baseline and general characteristics of 596 published protocols of RCTs.
General characteristics First period Sept 2001-Dec 2004 Second period Jan 2005-May 2008 Third period Jun 2008-Sept 2011 p-value
(number) (percentage) (n) (%) (n) (%) (n) (%)
Total 69 (12) 137 (23) 390 (65) <0.0001
Region;
Europe 24 (35) 65 (47) 190 (49)
North America 30 (44) 46 (34) 103 (26)
Australasia 11 (16) 25 (18) 86 (22)
Other 4 (6) 1 (1) 11 (3) 0.02
Specialty;
Internal medicine and paediatrics 35 (51) 75 (55) 164 (42)
Primary care 23 (33) 38 (28) 115 (40)
Surgery 6 (9) 19 (14) 41 (11)
Other 5 (7) 5 (4) 30 (8) 0.06
Participating countries;
Single country 42 (61) 94 (69) 312 (80)
Two or more countries 22 (32) 31 (23) 68 (17)
Missing 5 (7) 12 (9) 10 (3) 0.006
Participating centres;
Single 8 (12) 28 (20) 94 (24)
Multi 61 (88) 109 (80) 296 (76) 0.06
Funding;
Commercial 33 (48) 46 (34) 113 (29)
Non-commercial 36 (52) 91 (66) 277 (71) 0.008
Trial design;
Parallel 56 (81) 120 (88) 325 (83)
Other/Mixed 13 (19) 17 (12) 65 (17) 0.39
Number of study arms reported;
Two arms 43 (62) 105 (77) 299 (77)
Three or more arms 26 (38) 32 (23) 90 (23) 0.032
Number of randomized patients; 640 358 336
Median (IQR) (308–2741) (197–852) (140–900)
Written informed consent
present;
41 (59) 106 (77) 287 (74) 0.02
Data safety Committee present; 37 (54) 57 (42) 139 (37) 0.02
Plan for adverse events present; 17 (25) 50 (37) 145 (37) 0.13
Legend: This table describes all general characteristics of the included protocols, divided period by of publication. Study groups were compared by Fisher
exact, χ2 and Mann-Whitney U tests, as appropriate. A p-value of <0.05 was considered significant. IQR = inter quartile range.
https://doi.org/10.1371/journal.pone.0173042.t001
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The proportion of high quality protocols increased non-significantly across the study peri-
ods: 18 (26%), 43 (31%) and 143 (37%), (p = 0.17). Adequate methods for generation and con-
cealment of allocation improved significantly over time (p = 0.03). Blinding was applied
relatively frequent (about 70%) throughout the study periods, while the use of a blinded
observer increased from 48% in the first period to 67 (60%) in the third (p = 0.02). The number
of studies attempting to blind patients decreased significantly over time: from 39% and 37% in
the first two periods, respectively, to 26% in the third (p = 0.02). The rate of double-blinding
also decreased accordingly, from 39% and 36% to 25%, respectively (p<0.008). There was a
non-significant increase in explicit intention-to-treat analysis, from 62% in the first period to
75% in the third (p = 0.08).
Subgroup and regression analysis
Subgroup analysis by geographic region is presented in Table 3.
Table 2. Quality characteristics of published protocols.
Individual quality
characteristics
First period Sept 2001-Dec 2004
n = 69
Second period Jan 2005-May 2008
n = 137
Third period Jun 2008-Sept 2011
n = 390
p-value
(number) (percentage) (n) (%) (n) (%) (n) (%)
Primary outcome specified; 65 (94) 134 (98) 380 (97) 0.3
Sample size calculation
reported;
64 (93) 123 (90) 359 (92) 0.7
Adequate generation of
allocation;
30 (44) 79 (56) 260 (67) 0.001
Concealment of allocation; 26 (38) 72 (53) 215 (55) 0.03
Any Blinding; 50 (73) 90 (66) 268 (69) 0.60
Blinding—patient;
Yes 27 (39) 50 (37) 103 (26)
No 35 (51) 75 (55) 274 (70)
Unclear 7 (10) 12 (9) 13 (3) 0.02
Blinding—observer;
Yes 33 (48) 67 (49) 235 (60)
No 22 (32) 48 (35) 122 (31)
Unclear 14 (20) 22 (16) 33 (9) 0.02
Blinding—physician;
Yes 25 (36) 37 (27) 76 (20)
No 36 (52) 86 (63) 297 (76)
Unclear 8 (12) 14 (10) 17 (4) 0.005
Blinding—adjudication committee;
Yes 17 (25) 22 (16) 40 (10)
No 52 (75) 114 (83) 350 (90)
Unclear 0 (0) 1 (1) 0 (0) 0.003
Double blinding; 27 (39) 49 (36) 97 (25) 0.008
Prospective subgroup
analyses;
16 (23) 37 (27) 80 (21) 0.3
Intention to treat analyses; 43 (62) 97 (71) 293 (75) 0.08
High quality protocols; * 18 (26) 43 (31) 143 (37) 0.2
Legend: This table describes all characteristics concerning methodological quality, subdivided by period of publication. Study groups were compared by
Fisher exact, χ2 and Mann-Whitney U tests, as appropriate. A p-value of <0.05 was considered significant.
* defined as presence of the following 3 criteria: adequate generation of allocation, concealment of allocation and intention-to-treat analysis.
https://doi.org/10.1371/journal.pone.0173042.t002
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Adequate generation and concealment of allocation were equally frequent in RCT protocols
from Europe and Australasia (around 60%), while less often so in protocols from North Amer-
ica (52% and 43%, respectively, p0.01). A similar trend was observed for adequate type of
planned analyses (i.e. explicitly intention to treat): 79% and 76% for European and Austral-
asian, respectively, compared to 60% for North American protocols (p<0.0001). However, for
blinding, North America achieved the highest percentages on practically all parameters. This is
reflected in a double-blinding proportion of 36% compared to 24% and 25% for European and
Australasian protocols, respectively (p = 0.02).
Subgroup analyses comparing the three most common specialties (Internal medicine and
paediatrics, primary care and surgery) were performed (Table 3). A significant difference in
adequate generation of allocation and adequate concealment allocation was observed with the
highest percentage achieved by surgery protocols (p = 0.02 and p = 0.002, respectively). On the
Table 3. Subgroup analyses by region and speciality.
Individual quality characteristics Europe n = 279 North America n = 179 Australasia n = 122 p-value
(number) (percentage) (n) (%) (n) (%) (n) (%)
Sample size calculation reported; 253 (91) 161 (90) 116 (95) 0.3
Primary outcome specified; 274 (98) 167 (93) 122 (100) 0.001
Generation of allocation; 183 (66) 94 (53) 79 (65) 0.01
Concealment of allocation; 154 (55) 77 (43) 72 (59) 0.009
Some blinding; 182 (65) 125 (70) 88 (72) 0.3
Blinding–patient; 71 (25) 66 (37) 34 (28) 0.03
Blinding–observer; 165 (59) 91 (51) 72 (59) 0.2
Blinding–physician; 47 (17) 61 (34) 22 (18) <0.0001
Blinding–adjudication committee; 20 (7) 37 (21) 17 (14) <0.0001
Double blinding; 68 (24) 65 (36) 31 (25) 0.02
Prospective subgroup analyses; 68 (24) 40 (22) 23 (19) 0.5
Intention to treat analyses; 221 (79) 108 (60) 93 (76) <0.0001
High quality protocols; * 99 (36) 45 (25) 53 (43) 0.003
Individual quality characteristics Internal & paediatrics n = 274 Primary care n = 216 Surgery n = 66 p-value
(number) (percentage) (n) (%) (n) (%) (n) (%)
Sample size calculation reported; 256 (93) 194 (90) 61 (92) 0.34
Primary outcome specified; 271 (99) 206 (95) 64 (97) 0.06
Generation of allocation; 153 (56) 140 (65) 48 (73) 0.02
Concealment of allocation; 120 (44) 127 (59) 38 (58) 0.002
Some blinding; 213 (78) 129 (60) 33 (50) <0.0001
Blinding–patient; 107 (39) 35 (16) 18 (27) <0.0001
Blinding–observer; 156 (57) 120 (56) 29 (44) 0.16
Blinding–physician; 89 (33) 24 (11) 13 (20) <0.0001
Blinding–adjudication committee; 66 (24) 7 (3) 3 (5) <0.0001
Double blinding; 104 (38) 33 (15) 18 (27) <0.0001
Prospective subgroup analyses; 68 (25) 41 (19) 14 (21) 0.30
Intention to treat analyses; 194 (71) 158 (73) 49 (74) 0.78
High quality protocols; * 77 (28) 80 (37) 29 (44) 0.02
Legend: This table describes the subgroup analysis for methodological quality characteristics subdivided by specialty or region. Study groups were
compared by Fisher exact, χ2 and Mann-Whitney U tests, as appropriate. A p-value of <0.05 was considered significant.
* Presence of the following three criteria: adequate generation of allocation, concealment of allocation and intention-to-treat analysis.
https://doi.org/10.1371/journal.pone.0173042.t003
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other hand internal medicine and paediatrics consistently scored the highest percentage for
blinding. The highest percentage of high quality protocols was in surgery (44%), (p = 0.018).
Univariate regression analysis shows origin from North America to be negatively associated
with methodological quality, while origin from Europe, primary care or surgery as specialty,
presence of informed consent and presence of a plan for adverse event were predictors for
high methodological quality. In multi-variate analysis, all these factors were confirmed as inde-
pendent predictors for methodological quality (Table 4).
Discussion
This first systematic empirical literature-based study on volume and quality of RCT protocols
found a five-fold increase in the number of RCT protocols published over a ten-year period.
Although the overall quality of published protocols improved, there were differences between
continents, with protocols from Australasia and Europe being of higher quality than those
Table 4. Regression analyses for high protocol quality.
Univariate regression analyses; Characteristics (n) Odds for high quality. OR (95% CI) p-value
Region;
Europe 279 1 -
North America 179 0.61 (0.40–0.93) 0.02
Australasia 122 1.40 (0.91–2.20) 0.13
Specialty;
Internal medicine and Paediatrics 274 1 -
Primary care 216 1.51 (1.03–2.20) 0.04
Surgery 66 2.01 (1.15–3.47) 0.01
Number of participating countries; Single country 448 0.86 (0.57–1.31) 0.5
Participating centres; Single 130 0.68 (0.44–1.04) 0.08
Funding; Commercial 192 1.14 (0.79–1.64) 0.5
Trial design; parallel 501 1.15 (0.72–1.85) 0.6
Two study arms reported; Yes 447 0.95 (0.64–1.41) 0.8
Written informed consent; Yes 434 1.50 (1.01–2.23) 0.04
Data safety committee present; Yes 233 1.18 (0.83–1.66) 0.4
Plan adverse events; Yes 212 1.69 (1.19–2.40) 0.003
Multivariate regression analyses; Characteristics (n) Odds for high quality. OR (95% CI) p-value
Region;*
Europe 257 1
North America 168 0.63 (0.40–0.99) 0.04
Australasia 117 1.30 (0.82–2.06) 0.3
Specialty;
Internal and paediatrics 262 1
Primary care 214 1.57 (1.04–2.36) 0.03
Surgical specialties 66 1.94 (1.09–3.45) 0.02
Written informed consent; Yes 434 1.42 (0.90–2.23) 0.13
Plan adverse events; Yes 212 1.81 (1.22–2.68) 0.003
Legend: This table describes odds ratio (OR) with the corresponding 95% confidence intervals (95% CIs),
and was calculated for comparison of methodological quality between subgroups by means of univariate and
multivariate logistic regression. A p-value of <0.05 was considered significant.
*The small number of protocols from regions labelled as “other” (e.g. Africa and South America) were not
included in the multivariate analysis, but are reported in Table 1.
https://doi.org/10.1371/journal.pone.0173042.t004
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from North America. This empirical literature-based study also found medical specialty to be
correlated with the quality of published RCT protocols. Both primary care and surgical trials
were associated with significantly higher quality compared to internal medicine and paediatric
protocols. However, the confidence intervals of these parameters were relatively broad. There-
fore it cannot be excluded that confounders that were not accounted for in the multivariate
analysis contributed to the overall significance.
Previous studies have identified similar trends for the volume of published RCTs, as for
published protocols.[26, 28–32] Whether protocol publication is increasing in popularity, or
whether the augmentation in volume can be subscribed as a direct consequence of the
increased amount of RCTs remains uncertain. In contrast with the current study, previous
studies found published RCTs from Australasia to have the lowest rates of adequate reporting.
[26, 33–36] The higher quality of surgical trials is remarkable especially since surgery used to
have a reputation of being based on tradition rather than scientific research.[37, 38] A possible
explanation for this phenomenon could be that due to the increasing rate of technological
innovation more (e.g. minimally invasive) techniques have become available which allow for
randomized comparisons. Moreover, increased awareness of the importance of surgical trials
and enhanced training in trial methodology may have attributed to this improvement, but
data are lacking. The recent IDEAL (Idea, Development, Exploration, Assessment, Long-term
Follow-up) framework for surgical innovation may provide guidance for further improvement
of trials on surgical interventions.[39, 40]
A troubling, and yet unexplained, finding is the apparent decrease in the use of a data safety
committee from 54% in the first period to 36% in the third period. Close monitoring of this
development is imperative.[41] In fact, the presence of a plan to handle adverse events seemed
to be the strongest indicator for high quality RCT protocols. This might be explained by the
importance of having such a plan is especially important in trials with a high degree of trial
complexity; such trials will have been designed more carefully.[42] The intention of gaining
written informed consent was also found to be a marker for high protocol quality. It seems
that evidence-based guidance on how to design and perform RCTs would be welcomed. The
Trial Forge platform and the SPIRIT guidelines (Standard Protocol Items: Recommendations
for Interventional Trials) could be instrumental in this aspect as it strives to provide a system-
atic approach to improving trials and their protocols.[43, 44]
A shortcoming of our study is that the quality of the protocol does not automatically trans-
late into the quality of the RCT. Although previous studies have compared the quality of RCTs
with the quality of their protocols, such studies are scarce. Furthermore, they have used small
samples and some of their results are contradictory.[9, 15, 45] Whether the trials described in
the protocols in our study will be performed and published as designed, should be investigated
further. This might reveal important insights in the life cycle of RCTs, and would allow prospec-
tive evaluation of factors that might be related to early termination of RCTs and non-publica-
tion. Another shortcoming of this study is that instead of the SPIRIT guidelines, the Cochrane
risk of bias tool was used. The use of the SPIRIT item check list would have expanded the analy-
sis. The drawback of the SPIRIT checklist, however, is that it covers over 50 items, including
recommendations on version identifiers and statements regarding who obtained informed con-
sent and who have access to the final data. These data are often not available in the published
protocols. Therefore, a more selective approach was chosen in which a selected list of items was
evaluated with empirical evidence showing their importance in that they affect final outcomes
of RCTs. Additionally, the fact that these items have been used previously in several studies
allows comparison between studies.
Medical specialties were subdivided into three fairly broad and subjective groups, in order
to compare and contrast our findings across this range of subspecialties. This might have
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resulted in a loss of detail.[28, 29] Furthermore, only protocols published in English were
included, which may have led to an underestimation of the number of published protocols,
assuming that some are published in other languages. The inclusion of protocols was not lim-
ited to the top listed medical journals, which is a strength of this study. Also our review covers
all medical specialties, which makes our study results generalizable.
In conclusion, this systematic review found a five-fold increase in the number of published
study protocols in the past decade. The methodological quality of the protocols improved dur-
ing the same period but varies greatly between regions and medical specialties, which suggests
that different regions and medical specialties may face different challenges when seeking to
improve the quality of RCTs. Nevertheless, it is important to strive for such improvements,
given the importance of RCTs and systematic reviews of them as a source of reliable and robust
evidence on the effects of healthcare interventions. Comprehensive training in RCT methodol-
ogy, as for example is already offered in a master programme at the University of Oxford,
amongst others, could benefit responsible conduct and reporting of RCTs greatly. The involve-
ment of international medical societies in developing standards for training could enhance
RCT quality improvement world-wide.
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